Abeona Therapeutics Inc.
ABEO
$6.54
-$0.20-2.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.36% | -17.62% | -58.84% | -33.79% | -186.48% |
| Total Depreciation and Amortization | -1.19% | -9.10% | -18.19% | -24.58% | -30.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -137.63% | -41.69% | 203.22% | 341.33% | 394.06% |
| Change in Net Operating Assets | -92.44% | -145.13% | 106.88% | 136.10% | 61.60% |
| Cash from Operations | -50.44% | -51.36% | -16.58% | 1.42% | 4.18% |
| Capital Expenditure | -272.55% | -638.97% | -488.40% | -447.65% | -242.04% |
| Sale of Property, Plant, and Equipment | -91.18% | -91.18% | -89.43% | -89.91% | -88.24% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -162.42% | -11,088.66% | -22.18% | -252.45% | 62.22% |
| Cash from Investing | -177.09% | -18,965.38% | -27.25% | -264.78% | 56.98% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 96.34% | 129.02% | 21.45% | 106.93% | -6.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 58.39% | -348.49% | -12,276.92% | -14,500.00% | -32,525.00% |
| Cash from Financing | 36.75% | 181.02% | 46.90% | 141.87% | 44.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.60% | 3,370.31% | 282.93% | 616.41% | 160.75% |